Eurobio Scientific SA (ALERS):企業の製品パイプライン分析

◆英語タイトル:Eurobio Scientific SA (ALERS) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME7843PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eurobio Scientific SA (Eurobio), formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a molecular diagnostic test for thyroid cancer. Eurobio serves a range of therapeutic areas including infectious diseases, Alzheimer’s disease and cancer. The company commercializes in vitro diagnostic kits and instruments through its affiliate Ingen. It has presence in France and the US. Eurobio is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Eurobio Scientific SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Eurobio Scientific SA Company Overview
Eurobio Scientific SA Company Snapshot
Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
Eurobio Scientific SA – Pipeline Analysis Overview
Eurobio Scientific SA – Key Facts
Eurobio Scientific SA – Major Products and Services
Eurobio Scientific SA Pipeline Products by Development Stage
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA Pipeline Products Overview
CO-3S Companion Diagnostic Assay
CO-3S Companion Diagnostic Assay Product Overview
Companion Diagnostic Test – Breast Cancer
Companion Diagnostic Test – Breast Cancer Product Overview
DHT Dx15
DHT Dx15 Product Overview
DHT Dx15 Clinical Trial
DIAG-3S Diagnostic Assay
DIAG-3S Diagnostic Assay Product Overview
Disease Evolution Predictive Test – AIDS
Disease Evolution Predictive Test – AIDS Product Overview
EHT Dx 11
EHT Dx 11 Product Overview
EHT Dx 12
EHT Dx 12 Product Overview
EHT Dx13
EHT Dx13 Product Overview
EHT Dx14
EHT Dx14 Product Overview
EHT Dx23
EHT Dx23 Product Overview
T-COR 8 – Dengue Fever
T-COR 8 – Dengue Fever Product Overview
T-COR 8 – Meningitis
T-COR 8 – Meningitis Product Overview
Therapeutic Drug Monitoring Test – Resistant Cancer
Therapeutic Drug Monitoring Test – Resistant Cancer Product Overview
VAC-3S Companion Diagnostic Test
VAC-3S Companion Diagnostic Test Product Overview
Eurobio Scientific SA – Key Competitors
Eurobio Scientific SA – Key Employees
Eurobio Scientific SA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Eurobio Scientific SA, Recent Developments
Oct 15, 2019: Eurobio Scientific: Strong earnings growth for the first half of 2019
Jul 23, 2019: Eurobio Scientific’s activity for the first half of 2019: Strong growth of sales
Jan 29, 2019: Eurobio Scientific reaches the €50m sales mark in 2018
Jul 23, 2018: Eurobio Scientific: 2018 mid-year activity report
Jun 30, 2018: Eurobio Scientific announce 2018 mid year results
Feb 15, 2018: Diaxonhit: Exclusive distribution of the VERIGENE molecular biology platform
Mar 24, 2016: Diaxonhit: Further progress of commercial activity Initial sales of proprietary products
Jan 26, 2016: Diaxonhit: 2015 Consolidated Income: €29.5 M
Sep 24, 2015: Diaxonhit: 2015 mid-year results
Jul 30, 2015: Encouraging results of the first clinical study of the VAC-3S vaccine against HIV, for which DIAXONHIT develops Companion Diagnostic Assay CO-3S
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Eurobio Scientific SA Pipeline Products and Ongoing Clinical Trials Overview
Eurobio Scientific SA Pipeline Products by Equipment Type
Eurobio Scientific SA Pipeline Products by Indication
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA, Key Facts
Eurobio Scientific SA, Major Products and Services
Eurobio Scientific SA Number of Pipeline Products by Development Stage
Eurobio Scientific SA Pipeline Products Summary by Development Stage
Eurobio Scientific SA Ongoing Clinical Trials by Trial Status
Eurobio Scientific SA Ongoing Clinical Trials Summary
CO-3S Companion Diagnostic Assay - Product Status
CO-3S Companion Diagnostic Assay - Product Description
Companion Diagnostic Test - Breast Cancer - Product Status
Companion Diagnostic Test - Breast Cancer - Product Description
DHT Dx15 - Product Status
DHT Dx15 - Product Description
DHT Dx15 - Clinical Validation of the Diagnostic Performance of a Molecular Signature to Determine the Malignant or Benign Profile of a Thyroid Nodule with Indeterminate Cytological Analysis
DIAG-3S Diagnostic Assay - Product Status
DIAG-3S Diagnostic Assay - Product Description
Disease Evolution Predictive Test - AIDS - Product Status
Disease Evolution Predictive Test - AIDS - Product Description
EHT Dx 11 - Product Status
EHT Dx 11 - Product Description
EHT Dx 12 - Product Status
EHT Dx 12 - Product Description
EHT Dx13 - Product Status
EHT Dx13 - Product Description
EHT Dx14 - Product Status
EHT Dx14 - Product Description
EHT Dx23 - Product Status
EHT Dx23 - Product Description
T-COR 8 - Dengue Fever - Product Status
T-COR 8 - Dengue Fever - Product Description
T-COR 8 - Meningitis - Product Status
T-COR 8 - Meningitis - Product Description
Therapeutic Drug Monitoring Test - Resistant Cancer - Product Status
Therapeutic Drug Monitoring Test - Resistant Cancer - Product Description
VAC-3S Companion Diagnostic Test - Product Status
VAC-3S Companion Diagnostic Test - Product Description
Eurobio Scientific SA, Key Employees
Eurobio Scientific SA, Other Locations
Eurobio Scientific SA, Subsidiaries
Glossary

★海外企業調査レポート[Eurobio Scientific SA (ALERS):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Schroders plc:戦略・SWOT・企業財務分析
    Schroders plc - Strategy, SWOT and Corporate Finance Report Summary Schroders plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Vantage Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gyne …
  • The Norinchukin Bank
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • Heron Resources Ltd:企業の戦略・SWOT・財務分析
    Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Heron Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • McGill University:製薬・医療:M&Aディール及び事業提携情報
    Summary McGill University (McGill) is a medical-doctoral university. The institute offers undergraduate, graduate, post-graduate courses besides research programs. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, e …
  • Citizens Electric Corporation:企業の発電所・SWOT分析2018
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Ck Hutchison Holdings Ltd:企業の戦略・SWOT・財務分析
    Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Ck Hutchison Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Citius Pharmaceuticals Inc (CTXR):企業の財務・戦略的SWOT分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc is a specialty pharmaceutical company that focuses on the development and commercialization of anti-infective products in adjunct cancer care, and critical care drug products. The company’s proprietary product candidates include Min …
  • American Electric Power Co Inc (AEP):電力:M&Aディール及び事業提携情報
    Summary American Electric Power Company, Inc. (AEP) is a holding company that carries out the generation, transmission and distribution of electricity through its subsidiaries. The company generates electricity through various sources of energy such as coal and lignite, natural gas, nuclear, and hyd …
  • JACCS Co Ltd:企業の戦略・SWOT・財務分析
    JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report Summary JACCS Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Getinge AB:企業の戦略・SWOT・財務情報
    Getinge AB - Strategy, SWOT and Corporate Finance Report Summary Getinge AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Bangkok Bank Public Co Ltd:戦略・SWOT・企業財務分析
    Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bangkok Bank Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Somany Ceramics Limited (SOMANYCERA):企業の財務・戦略的SWOT分析
    Somany Ceramics Limited (SOMANYCERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Sherritt International Corp (S):石油・ガス:M&Aディール及び事業提携情報
    Summary Sherritt International Corp (Sherritt) is a natural resources company. It carries out mining and refining activities for the production of nickel and cobalt from lateritic ores with ownership stake in Moa Joint Venture and Ambatovy Joint Venture. The company also explores, develops and produ …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • LG Corp (003550):企業の財務・戦略的SWOT分析
    LG Corp (003550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • JEA:発電所・企業SWOT分析
    JEA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • A. Menarini Asia-Pacific Holdings Pte Ltd-製薬・医療分野:企業M&A・提携分析
    Summary A. Menarini Asia-Pacific Holdings Pte Ltd (A. Menarini Asia-Pacific), formerly Invida Group Pte Ltd, a subsidiary of A. Menarini Industrie Farmaceutiche Riunite Srl is a biopharmaceutical company that develops consumer health care products. The company operates through its divisions includin …
  • Myer Holdings Ltd:企業の戦略・SWOT・財務分析
    Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆